Ewing sarcoma family of tumors

Current Opinion in Oncology

Volumn 12, Issue 4, 2000, Pages 323-329

  West, Daniel C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; IFOSFAMIDE;

ADENOVIRUS 5; CHROMOSOME TRANSLOCATION; DNA FLANKING REGION; EWING SARCOMA; FUSION GENE; GENE EXPRESSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 22; CLINICAL TRIALS; HUMANS; ONCOGENE PROTEINS, FUSION; SARCOMA, EWING'S; TRANSCRIPTION FACTORS;

EID: 0034502408     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200007000-00008     Document Type: Review

References (46)

1. Trends in cancer incidence among children in the U.S.
2. Bone sarcomas linked to radiotherapy and chemotherapy in children
3. Bone tumors among the atomic bomb survivors of Hiroshima and Nagasaki
4. Round cell tumors of bone
5. Pediatric peripheral neuroectodermal tumors, oncogenes and differentiation
6. Neural and mesenchymal differentiation in Ewing's sarcoma cell lines morphological, immunophenotypic, molecular biological and cytogenetic evidence
7. Neural differrentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22(q24;q12)
8. Experimental evidence for a neural origin of Ewing's sarcoma of bone
9. An association between viral genes and human oncogenic alterations: The adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1
10. E1A and the Ewing tumor translocation
11. E1A and the Ewing tumor translocation
12. Adenovirus E1A and Ewing tumors
13. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors
14. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints
15. The Ewing family of tumors- a subgroup of small-round-cell tumors defined by specific chimeric transcripts
16. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that require the DNA-binding domain encoded by FLI1 for transformation
17. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1
18. The FLI-1 and chimeric EWS-FLI-1 oncoprotein display similar DNA binding specificities
19. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma
20. EWS/FLi-1 chimeric protein is a transcriptional activator
21. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor
22. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic
23. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms
24. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncopiolein
25. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with EWS-FLI1
26. Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: A possible therapeutic target
27. The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts
28. Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors
29. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?
30. EWS-FLI fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma
31. Differential transactivation by alternatire EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma
32. Adding ifosfamide and etoposide to vincristine, cyclophosphamide, adriamycin, and actinomycin improves outcome in non-metastatic Ewing's sarcoma and PNET: Update of CCG/POG study
33. Italian cooperative study for the treatment of children and young adults with locolized Ewing sarcoma of bone
34. Chemotherapy in Ewing's sarcoma
35. Nonmetastatic pelvic Ewing sarcoma: Report of the French Society of Pediatric Oncology
36. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremeties
37. Pelvic Ewing sarcoma: A retrospective analysis of 241 cases
38. Chemotherapy dose intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round cell tumors: A feasibility study at St. Jude Children's Research Hospital
39. Cutaneous and subcutaneous Ewing's sarcoma: An indolent disease
40. Adults with Ewing's sarcoma/primitive neuroectodermal tumor
41. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Instituto Ortopedico Rizzoli
42. Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior
43. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma
44. Prognostic impact of deletions of 1p36 and numerical aberrations in Ewing tumors
45. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors
46. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone. The Dana-Farber Canape Institute/Children's Hospital experience